City and County of San Francisco v. Purdue Pharma L.P.

District Court, N.D. California·Decided March 8, 2021·No. 3:18-cv-07591·Unknown

Opinion

1 2 3 4 5 IN THE UNITED STATES DISTRICT COURT 6 FOR THE NORTHERN DISTRICT OF CALIFORNIA 7 8 CITY AND COUNTY OF SAN Case No. 18-cv-07591-CRB FRANCISCO, et al., 9 Plaintiffs, ORDER RE: PLAINTIFF’S FIRST AND 10 SECOND SET OF RFPDS TO ENDO v. 11 Re: Dkt. 461 and 474 PURDUE PHARMA L.P., et al., 12 Defendants. 13 14 INTRODUCTION 15 Now pending before the Court is a joint discovery letter filed by Plaintiff and Endo 16 Pharmaceuticals, Inc. and its subsidiaries (“Endo” and together with Plaintiff, the “Parties”), 17 summarizing the existing discovery-related disputes between the Parties. See Dkt. 461; Dkt. 474. 18 The discovery disputes addressed therein were discussed at oral argument on March 3, 2021. See 19 Dkt. 470. At oral argument, the Court directed the Parties to submit a revised version of the 20 discovery letter brief with sub-docketed exhibits. Id. The Parties complied and have produced a 21 sub-docketed discovery letter. See Dkt. 474. 22 There are four issues raised in the discovery letter brief: first, whether Plaintiff is bound by 23 the MDL search terms Endo provided in August 2020 and September 2020 in response to 24 Plaintiff’s First Set of RFPDs; second, whether Endo’s written responses to Set Two of Plaintiff’s 25 RFPDs are insufficient under Rule 34 of the Federal Rules of Civil Procedure (“Rule 34”) and 26 need be amended to identify documents by Bates number; third, whether Endo can lawfully refuse 27 to produce additional custodians and materials related to its subsidiary Par’s unbranded marketing 1 backup tapes in its possession related to Eric Vandal, a former Endo executive involved in the 2 marketing of Percocet. See Dkt. 474 at 1-8. 3 After carefully considering the Parties’ submissions, the Court concludes as follows. First, 4 the Court DENIES without prejudice Plaintiff’s motion to compel Endo to implement the 5 jurisdiction-specific search terms that Plaintiff has proposed. See Dkt. 474 at 1; Dkt. 474-3. 6 Second, the Court DENIES without prejudice Plaintiff’s motion to compel production of Eric 7 Vandal’s custodial file. See Dkt. 474 at 3. The Parties shall meet and confer on each of these 8 issues and, if no resolution is reached by March 12, 2021, the Parties shall submit a joint discovery 9 dispute letter to the Court outlining the remaining disputes. Third, with respect to Endo’s written 10 responses to Set Two of Plaintiff’s RFPDs, the Court is satisfied with Endo’s responses and 11 citation to Bates number ranges and, therefore, DENIES Plaintiff’s motion to compel more 12 detailed responses. See id. at 2, 5-6; generally Dkt. 474-15. Fourth, with respect to Par’s 13 unbranded marketing efforts, the Court GRANTS Plaintiff’s motion to compel and orders Endo to: 14 (1) identify additional custodians responsible for Par’s unbranded marketing efforts; and (2) to 15 produce documents related to Par’s marketing campaigns requested in Plaintiff’s First and Second 16 Set of RFPDS. See Dkt. 474 at 3; also Dkt. 474-7 at 10; Dkt. 474-8 at 7; Dkt. 474-9 at 3. 17 The Court’s analysis on each issue is provided in greater depth below. 18 DISCUSSION 19 A. Jurisdiction-Specific Search Terms 20 The first issue is whether the additional jurisdiction-specific case discovery search terms 21 proposed by Plaintiff are proper and timely. See Dkt. 474 at 1.1 At oral argument on March 3, 22 2021, Endo lamented that Plaintiff’s request to compel production of discovery related to the 23 newly proposed search terms was “premature.” See Dkt. 470. That is, because Endo provided its 24 counterproposal to Plaintiff’s jurisdiction-specific search terms on the night of March 2, 2021 (and 25 the hearing occurred on the morning of March 3, 2021), the issue was not ripe for resolution as 26

27 1 The additional search terms were first proposed by Plaintiff on January 8, 2021. See id. The 1 Endo was still awaiting a response on its counterproposal from Plaintiff. See id. The Court 2 understands that the Parties are now in good faith negotiating the inclusion of the jurisdiction- 3 specific search terms and, therefore, the Court will not intervene. The Parties shall meet and 4 confer to discuss the issue by March 12, 2021. If the Parties cannot agree upon the scope of the 5 jurisdiction-specific search terms by that date, they shall jointly submit a discovery dispute letter 6 to the Court to resolve the issue. 7 Regardless of the Parties’ ongoing negotiations, the timeliness of Plaintiff’s proposals can 8 still be addressed. Endo argued in the discovery letter brief that Plaintiff’s request for additional 9 search terms was untimely. See Dkt. 474.2 Specifically, Endo claims that on December 2, 2020, 10 Endo “informed Plaintiff that they would utilize the search terms described in August 2020 [the 11 MDL search terms], as well as additional search terms targeting diversion-and-compliance-related 12 materials applied to custodians with responsibilities to Opana ER in the Bay Area. According to 13 Endo, Plaintiff raised no concerns about the existing search terms at that time, “nor did Plaintiff 14 propose any ‘migration-specific’ terms that Plaintiff now contends are necessary.” Dkt. 474 at 4 15 (internal footnote omitted) (citing Dkt. 474-12). For its part, Plaintiff argues the search terms are 16 being provided “in furtherance of this Court’s December 21, 2020 order regarding additional 17 custodians and the applicable temporal scope of Plaintiff’s First Set of RFPDs, and in advance of 18 the Endo Defendants’ responses to Plaintiff’s Second Set of RFPDs, Served on December 3, 19 2020.” Id. at 1 (citing Ex. 1). 20 The Court agrees with Plaintiff that its proposals are timely. On January 8, 2021, when 21 Plaintiff first proposed additional search terms to Endo, Plaintiff asked Endo to notify counsel 22 immediately “if they had any questions or concerns about applying the search terms.” Id. at 1. 23 Endo voiced no objections until January 29, 2021, three weeks later. See id. Moreover, Endo has 24 consistently responded to the relevant RFPD with objections only, arguing that it does not 25 understand what “migration” means and thereby delaying the dispute around the addition of 26 jurisdiction-specific search terms. See id. at 1. Endo has, at least as of March 2, 2021 (the night 27 1 before the Parties’ hearing on the matter), also failed to identify which search terms it objects to 2 and why. See id. Additionally, allowing the Parties to continue negotiations on this topic would 3 not prejudice Endo. In fact, Endo sent a list of jurisdiction-specific search terms to Plaintiff as 4 recently as March 2, 2021, indicating a willingness to negotiate. See Dkt. 470. Moreover, Endo’s 5 counsel stated at oral argument that it has produced documents related to the current, agreed-upon 6 search terms within the past few weeks. Id. Endo’s counterproposal and its ongoing productions 7 on this matter undermine its argument that Plaintiff’s submissions were untimely.3 8 B. Sufficiency of Endo’s Bates Number References 9 The second issue is whether Endo’s written responses to Set Two of Plaintiff’s RFPDs 10 comply with Rule 34. See Dkt. 474 at 2. Plaintiff argues that Endo improperly relies on past 11 productions without identifying documents by Bates number. See id. Endo counters that its 12 responses “provide specific objections tailored to each of Plaintiff’s requests” and points to several 13 exhibits that purportedly demonstrate compliance. See id. at 5 (citing Dkt. 474-15, Dkt. 474-16, 14 and Dkt. 474-17). Additionally, Endo points out that Rule 34 is not as demanding as Plaintiff 15 suggests. See Dkt. 474 at 5 (citing Fed. R. Civ. P. 34

Free access — add to your briefcase to read the full text and ask questions with AI

City and County of San Francisco v. Purdue Pharma L.P., (N.D. Cal. 2021).

City and County of San Francisco v. Purdue Pharma L.P. (City and County of San Francisco v. Purdue Pharma L.P.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.